Quantification of cerebrospinal fluid flow in dogs by cardiac‐gated phase‐contrast magnetic resonance imaging by Christen, Muriel A. et al.
S T ANDA RD AR T I C L E
Quantification of cerebrospinal fluid flow in dogs by
cardiac-gated phase-contrast magnetic resonance imaging
Muriel A. Christen1 | Daniela Schweizer-Gorgas1 | Henning Richter2 |
Fabiola B. Joerger3 | Matthias Dennler2
1Division of Clinical Radiology, Vetsuisse
Faculty, University of Bern, Bern, Switzerland
2Clinic of Diagnostic Imaging, Vetsuisse
Faculty, University of Zurich, Zurich,
Switzerland
3Department of Clinical Diagnostics and
Services, Vetsuisse Faculty, University of
Zurich, Zurich, Switzerland
Correspondence
Daniela Schweizer-Gorgas, Division of Clinical
Radiology, Vetsuisse Faculty, University of
Bern, Bern 3012, Switzerland.
Email: daniela.schweizer@vetsuisse.unibe.ch
Funding information
Albert Heim foundation, Swiss Cynological
Society, Switzerland.
Abstract
Background: Cerebrospinal fluid (CSF) flow in disease has been investigated with
two-dimensional (2D) phase-contrast magnetic resonance imaging (PC-MRI) in
humans. Despite similar diseases occurring in dogs, PC-MRI is not routinely per-
formed and CSF flow and its association with diseases is poorly understood.
Objectives: To adapt 2D and four-dimensional (4D) PC-MRI to dogs and to apply
them in a group of neurologically healthy dogs.
Animals: Six adult Beagle dogs of a research colony.
Methods: Prospective, experimental study. Sequences were first optimized on a
phantom mimicking small CSF spaces and low velocity flow. Then, 4D PC-MRI and
2D PC-MRI at the level of the mesencephalic aqueduct, foramen magnum (FM), and
cervical spine were performed.
Results: CSF displayed a bidirectional flow pattern on 2D PC-MRI at each location.
Mean peak velocity (and range) in cm/s was 0.92 (0.51-2.08) within the mesence-
phalic aqueduct, 1.84 (0.89-2.73) and 1.17 (0.75-1.8) in the ventral and dorsal sub-
arachnoid space (SAS) at the FM, and 2.03 (range 1.1-3.0) and 1.27 (range 0.96-1.82)
within the ventral and dorsal SAS of the cervical spine. With 4D PC-MRI, flow veloci-
ties of >3 cm/s were visualized in the phantom, but no flow data were obtained
in dogs.
Conclusion: Peak flow velocities were measured with 2D PC-MRI at all 3 locations
and slower velocities were recorded in healthy Beagle dogs compared to humans.
These values serve as baseline for future applications. The current technical settings
did not allow measurement of CSF flow in Beagle dogs by 4D PC-MRI.
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1 | INTRODUCTION
The 3 main functions of cerebrospinal fluid (CSF) are the regulation of
the intracranial volume, maintenance of the chemical environment of
Abbreviations: 2D, two-dimensional; 4D, four-dimensional; CKCS, Cavalier King Charles
Spaniel; CSF, cerebrospinal fluid; FM, foramen magnum; FOV, field of view; NSA, number of
signal averages; PC-MRI, phase-contrast magnetic resonance imaging; ROI, region of interest;
SAS, subarachnoid space; SNR, signal-to-noise ratio; TR, repetition time.
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the central nervous system, and transport of biologically active sub-
stances. The choroid plexus as the sole source of CSF is debated,
but its constant production creates a pressure that dictates the
direction of the fluid flow through the ventricular system to the
subarachnoid space (SAS).1,2 This so-called CSF bulk flow occurs
over minutes. In addition, there is a pulsatile flow modulated by the
expansion of intracranial vessels during every systole because of a
mild increase in intracranial volume.3-5 As compensation, CSF is
displaced from intracranial to spinal CSF spaces in systole and back
in diastole, leading to a bidirectional pulsatile flow.5-7 Likewise, the
respiratory cycle contributes to CSF flow—variations of intratho-
racic pressure evoke changes in the epidural venous plexus.8
Abnormal CSF flow patterns and alteration of CSF flow velocity
occur in a variety of diseases, mainly due to stenosis or obstruction
of CSF spaces, which might result in secondary disorders of the
ventricular system like hydrocephalus or cyst-like lesions within the
forebrain, spinal cord, or both.9-18
Phase-contrast magnetic resonance imaging (PC-MRI) is a non-
invasive method to quantify flow velocities and to characterize
flow patterns. In two-dimensional (2D) PC-MRI, a bipolar gradient
with equal magnitude induces a net phase shift of moving protons,
which is proportional to their velocity. Cardiac gating encompasses
bidirectional flow measurements during a cardiac cycle and velocity
data are presented as coded grayscale values with negative values
displayed as dark and positive values as bright pixels on the phase
images, depending on flow direction and velocity.19,20 New devel-
opments have enabled the measurement and visualization of flow
in all 3 spatial dimensions and over time, known as four-
dimensional (4D) PC-MRI.21,22 In humans, PC-MRI can determine
the degree and location of CSF stenosis within the ventricles and
the SAS, provide information for surgical planning, and assess post-
surgical success.7,9,10,14,16,17,23
Toy breed dogs and brachycephalic dogs in particular show
abnormalities of CSF spaces in MRI similar to humans.24-28 However,
only limited velocity data are available in dogs and the only existing
study in dogs demonstrated a lower peak velocity in Cavalier King
Charles Spaniels (CKCS) compared to control dogs at the foramen
magnum (FM). Furthermore, this investigation revealed that the com-
bination of slower CSF peak velocity in the dorsal SAS at the level
C2-C3 intervertebral disc and higher peak velocity at the level of the
FM in CKCS was associated with syringomyelia in CKCS.29 Despite
these promising results, PC-MRI is not implemented as a diagnostic
tool to detect CSF flow abnormalities in dogs with hydrocephalus,
syringomyelia, or other conditions indicative of stenosis of CSF flow.
Challenges for the acquisition of PC-MRI in dogs with sufficient signal
to measure flow velocities arise from the smaller CSF spaces, higher
heart rate in dogs, the slower flow velocity compared to humans,29-31
and the lack of normative data to compare with.
The aim of this prospective study is to optimize 2D and 4D PC-
MRI for the smaller CSF spaces and slower flow velocity in dogs, to
provide normative values from neurologically healthy dogs with nor-
mal appearance of CSF spaces on MRI.
2 | MATERIALS AND METHODS
2.1 | Phantom study
The 2D and 4D PC-MRI sequences were adapted for the ana-
tomical differences in dogs compared to humans on a phantom
mimicking the smaller CSF spaces and slower CSF flow velocity.
A 20 × 15 × 15 cm plastic box was filled with gelatin, embedding
3 infusion lines with a diameter of 2.5 mm, 1.5 mm, and 1.0 mm
as straight segments with a U-turn. The infusion lines were con-
nected to a medical perfusion pump outside the MRI room
(Syramed μSP6000; arcomed, Regensdorf, Switzerland). The per-
fusion syringes were filled with water with a similar viscosity to
CSF. The liquid flowed from the small to the large diameter infu-
sion lines to reduce the effect of higher resistance in the small
lines. Flow velocity was calculated with a linear stream-profile
conversion table (volume to flow velocity). Measurements were
repeated when the velocity was gradually reduced.
The phantom was placed in a 3T magnetic resonance system
(Philips Ingenia scanner, Philips AG, the Netherlands) with a
SENSE-head and neck coil. A cardiac frequency with a heartbeat
of 100 bpm was simulated by a physiological simulation setting
on the Philips software. 3D T1- and 3D T2-weighted images
were performed as planning sequences. The 2D and 4D PC-MRI
sequences were aligned perpendicular to the flow in the perfu-
sion lines. First to be tested were sequence parameters for bet-
ter signal-to-noise ratio (SNR) with a voxel size of 1 × 1 × 5 mm
with different numbers of acquisitions (NSA 1 and 2), field of
view (FOV 140/140, 150/150), and flip angle (15 and 20). The
measurements were performed once for each parameter and
subjectively evaluated for good SNR. Finally, to find the closest
velocity encoding the speed in the infusion lines, without getting
aliasing but still having good SNR, different velocities encoding
from 10 cm/s to 1 cm/s were tested. Additionally, for the 4D PC-
MRI sequence, both available accelerating techniques, kt-BLAST
and SENSE, were tested for their effect on scan time and
signal.19,20,32
The image acquisition and assessment of image quality was per-
formed by the first author, a PhD student with a Master's degree in
veterinary medicine under supervision and advice of a senior radiolo-
gist (ECVDI Diplomate). Technical support concerning the 4D
sequence was provided by a senior scientist in biomedical engineering
with expertise in motion encoding.
Concerning the 2D sequences, further support was provided by a
Professor of Radiology and Biomedical Engineering with a research
focus on blood and CSF flow dynamics using flow-sensitive MRI
techniques.
A decision of sufficient image quality was made based on the
velocity-to-noise ratio, that is, the ability to detect a change of gray
scale value in time of a pixel undergoing a phase shift. The final deci-
sion on acquisition parameters was made in consensus between first
and last authors.
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2.2 | Animals
The study was conducted with 6, adult, purpose-bred, research Beagle
dogs. Sex was equally distributed. The dogs were also used in another
parallel research study, which did not interfere with our research aims
and allowed the reduction of the number of experimental animals
used (3R reduce). The study population had a mean age of 7.42 years
(median = 7.65; range 5-10) and a mean bodyweight of 13.6 kg
(median 13.4; range 11.0-18). All dogs were declared healthy on clini-
cal neurological examination and showed no structural brain abnor-
malities on MRI (3D T2-weighted and T1-weighted images; Figure 1).
The dogs were fasted prior to anesthesia and premedicated with
0.2 mg/kg methadone (Methadon Streuli; Streuli Pharma AG, Switzer-
land) intramuscularly. An intravenous (IV) catheter (VasoVet 22G,
Eickemeyer, Switzerland) was placed aseptically in the cephalic vein.
Dogs were preoxygenated with a facemask with a flow of 4 L/min O2
for 5 minutes. Anesthesia was induced with propofol (Propofol 1%
MCT Fresenius; Fresenius Kabi AG, Switzerland) titrated to effect.
The tracheae of the dogs were intubated and sevoflurane (Sevorane,
AbbVie AG, Switzerland) in O2 and air (Fi O2 = 60%) was administered
to effect, depending on the plane of anesthesia, with an end-tidal con-
centration between 1.8 and 3.3 vol%. The dogs were mechanically
ventilated (Aestiva S5, 7900 SmartVent, Anandic Medical Systems
AG, Switzerland) with a pressure-controlled mode (8-11 cm H2O). The
respiratory rate was adjusted to achieve an end-tidal CO2 of 35 to
42 mm Hg (4.66-5.59 kPa). Acetated Ringer's solution (Ringer Acetat;
Fresenius Kabi AG, Switzerland) 5 mL/kg/h) was administered during
anesthesia. Body temperature was maintained between 37.5C and
39C and heart rate was maintained between 70 and 110 beats per
minute. If cardiac frequency increased to over 110 bpm, a fentanyl
(Fentanyl Sintetica; Sintetica, Switzerland) bolus of 2 μg/kg IV was
administered and repeated, if necessary. Anesthesia monitoring
included cardiovascular and respiratory variables, which were mea-
sured continuously and recorded by a multiparameter monitor (Datex
S5, Anandic Medical Systems AG, Switzerland) that included
pulsoxymetry, noninvasive blood pressure measurement, cap-
nography, inhalant gas analysis, spirometry, and vectorcardiography.
Mean blood pressure was kept above 65 mm Hg while heart rate was
kept below 110 beats per minute. Anesthesia depth was adapted as
necessary.
2.3 | Magnetic resonance imaging
All dogs were scanned in sternal recumbency with the head slightly
extended (<180 to the spinal cord) and elevated so that no pressure
developed on the jugular veins.3,4 The cardiac frequency was moni-
tored by a magnetic resonance compatible peripheral pulse unit
placed on the tongue and 2 magnetic resonance compatible electro-
cardiographic pads on each side of the thorax (Invivo 9312 ECG trans-
mitter, Philips AG, Zurich, Switzerland). Plane of anesthesia and
physiological parameters were stabilized if necessary with a fentanyl
bolus before initiating CSF flow studies.
MRI acquisition was performed by the first author under supervision
of a board certified senior radiologist. To exclude intracranial morphologi-
cal abnormalities and for alignment of PC-MRI sequences, 3D
T1-weighted (turbo field echo, repetition time [TR], 8.8 ms; echo time,
3.9 ms; flip angle, 8; FOV, 13 × 136 × 150 mm; voxel size,
0.6 × 0.6 × 0.6 mm) and 3D T2-weighted (turbo spin echo, TR, 2300 ms;
echo time, 171 ms; flip angle, 90; FOV, 170 × 130 × 157 mm; voxel
size, 0.7 × 0.7 × 0.7 mm) sagittal sequence were acquired.
The first PC-MRI sequence performed was a mid-sagittal PC-MRI
sequence to visualize pulsation of the CSF flow and to identify possi-
ble obstructions of CSF flow. The parameters for CSF measurements
in the sagittal plane were as follows: TR, 21 ms; echo time, 6.9; flip
angle, 10; FOV, 250 × 226 mm; slice thickness, 10 mm; voxel size,
0.98 × 1.4 mm; cardiac gating, retrospective; heart phases, 30; and
velocity encoding, 5 cm/s. Velocity encoding was reduced if the signal
was low or increased if aliasing occurred.
Further 2D PC-MRI sequences were acquired at 3 locations
perpendicular to the flow direction (Figure 1). The first measure-
ment was taken at the level of the mid-ampulla of the mesence-
phalic aqueduct. The second measurement at the level of the
caudal aspect of the occipital condyles to measure CSF within the
SAS of the FM. The third location was the atlantoaxial joint. In
1 dog, an additional measurement was performed perpendicular to
the SAS close to the intervertebral junction of C2/C3 after a low
signal was detected on the phase images in the dorsal SAS of
C1-C2 in 2 dogs. The 4D PC-MRI measurements covered the
entire brain parenchyma and the cervical spine as caudal as C4 in a
volumetric mode. The 4D measurements were performed once in
each dog (Figure 2).
2.4 | Postprocessing and image analysis
The postprocessing of the 2D data set was performed on an external
workstation (MR WorkSpace 2.6.3.5, Philips Medical System, the
F IGURE 1 T2-weighted mid-sagittal magnetic resonance image
of the brain and upper cervical spine of a Beagle. The yellow lines
illustrated the location of the phase-contrast sequence at the
mesencephalic aqueduct, the most caudal aspect of the foramen
magnum and at the atlantoaxial junction. Measurements were aligned
perpendicular to the flow direction
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Netherlands). The 4D PC data sets were processed by the GT-flow
software (Version 1.3.11, Gyrotools Ltd., Zurich, Switzerland).
Image analysis was performed by a single investigator (MC) who
was instructed and supervised by a board certified senior radiologist. For
all 3 locations, regions of interest (ROIs) were placed for each dog into
CSF spaces using magnitude and phase-contrast images in parallel in
order to match information of flow with the anatomy. ROIs were propa-
gated and manually adjusted to each of the 32 resulting phase images.
One ROI was drawn at the level of the mid-ampulla of the mesence-
phalic aqueduct. On images of the caudal aspect of the occipital condyles
and the cranial cervical spine, 3 ROIs were placed in the SAS surrounding
the spinal cord: 1 ROI in the dorsal SAS and 2 ROIs in the ventral SAS to
avoid areas where no flow signal was present and to exclude the basilar
artery or spinal artery from the velocity measurements (Figure 3).
The software generated automatically a time velocity curve
shown as graph and listed mean, maximum, minimum, peak velocity in
cm/s, and flux in ml/s. Results are reported in peak velocities (cm/s)
since average flow underestimates velocity measurements.4,29,33
On the acquired data from the 6 dogs, all ROIs were placed
3 times at least 3 days apart and the mean of the peak velocity is
reported.
Postprocessing of the 4D data set could not be performed due to
high velocity noise and low SNR on the phase images, which led to
undetectable velocity in CSF spaces.
2.5 | Statistical analysis
Descriptive analysis was performed with all values obtained. The data
were expressed as mean ± SD or median with range.
Intraobserver variability was assessed by calculating the
SEM based on 3 measurements on each location of the 2D phase
images. The statistical distributions of the velocities were visu-
ally examined using histograms and quantile plots and tested for
normality using the Shapiro-Wilk test (P ≤ .05, R 1.0.143
2009-2016).
F IGURE 2 Magnitude (A) and phase images (B,C) at the level of atlantoaxial junction. On the phase image, every pixel carries velocity
information. Cerebrospinal fuid (CSF) flow in rostrocaudal direction is displayed as negative velocity values and appears black (B, yellow arrow
head). CSF flow in caudorostral direction is displayed as positive velocity values and appears white (C, yellow arrow head). Note the aliasing
displayed as black and white pixels within the vertebral vessels (B,C: black arrow head)
F IGURE 3 Transverse magnitude image close to the C2/C3 (dorsal is at the lower edge of the image) (A) with regions of interest (ROIs) drawn
within the ventral (yellow and orange) and dorsal (green) subarachnoid space. Time velocity curves in B represent the flow (in mL/s over time in
ms) of the corresponding ROI showing a biphasic flow pattern
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3 | RESULTS
3.1 | Phantom study
Best SNR was achieved using the following sequence parameters: TR,
shortest (calculated by the scanner according to the VENC); echo
time, shortest (calculated by the scanner according to the VENC); flip
angle, 15; FOV, 150 x 150 mm; slice thickness, 5 mm; voxel size,
0.58 × 0.83 mm; NSA, 1; heart phases, 32; cardiac gating, retrospec-
tive. Sequence acquisition time was no longer than 3 to 4 minutes.
With these parameter settings, flow was visible on the phase images
in all infusion line diameters (2.5-1 mm) with velocities under 1 cm/s.
In the phantom test, the calculation of the theoretical estimated
velocities in tubes of different diameter corresponded with the mea-
sured 2D PC-MRI velocities. Sufficient velocity-to-noise ratio for the
volumetric measurements with the 4D PC-MRI sequence was
achieved using the following parameters: TR, shortest; echo time,
shortest; flip angle, 5; FOV, 140 × 140 × 40 mm; voxel size,
1 × 0.99 × 1 mm; stacks, 1; slices, 40; slice orientation, coronal; NSA,
1; heart phases, 16; cardiac gating, retrospective, and acceleration
technique SENSE. Velocity encoding was selected at 10 cm/s in all
spatial directions (RL-AP-FH). Alteration of these parameters to
improve velocity-to-noise ratio and SNR, such as reduction of voxel
sizes for detection of flow in small spaces or lowering velocity
encoding, increased the time of the sequence to >14 minutes despite
the use of SENSE acceleration. Flow signal could not be obtained on
the phase images with acceleration of kt-BLAST. A flow rate of
>3 cm/s was visible with a low SNR within the 2 larger infusion lines
(2.5 mm and 1.5 mm) but could not be detected in the smallest line
(1 mm). Flow rates below 3 cm/s could not be measured with the 4D
PC-MRI sequence.
3.2 | Animals
The 2D PC-MRI imaging enabled the assessment of CSF flow in every
dog. The acquisition time of CSF flow measurements at 3 locations
was between 3 and 4 minutes, and heart rate was between 70 and
110 bpm. A bidirectional flow pattern was visible on the sagittal phase
images in the dorsal and ventral SAS from the level of the FM to the
cervical spine, but not cranial to it. On transverse sequences, a bidirec-
tional flow pattern was visible in all ROIs except for the dorsal SAS of
C1-C2 of 2 dogs, where no signal could be detected. Velocity
encoding for measurements at the level of the FM and the cervical
spine was set at 5 cm/s for all dogs and then reduced to 3 cm/s at the
level of the aqueduct for better SNR. The shortest TR and TE were
calculated by the scanner according to the velocity encoding and was
for all transverse 2D PC-MRI sequences 16 to 17 ms and 10 ms,
respectively. The acquisition time for T1 weighted, T2 weighted, and
2D PC-MRI was 32 minutes; the 4D PC-MRI sequences took addi-
tional 14 minutes.
The CSF peak velocities resulting from all 3 measurements among
all dogs were normally distributed (Shapiro-Wilk test P ≤ .05). The
mean peak velocity of all 6 dogs for the different locations is listed in
Table 1. Peak velocity was the lowest at the level of the aqueduct and
the highest in the ventral SAS at the cervical spine. The peak velocities
in the dorsal SAS of the FM and cervical spine were lower when com-
pared to the ventral SAS. The peak velocities additionally measured at
the level of C2/C3 in dog Nr. 6 were as follows: ventral right SAS
2.94 cm/s, ventral left SAS 2.62 cm/s, and dorsal SAS 1.46 cm/s. Peak
velocities in the ventral SAS are higher at every measured position
than in the dorsal SAS, with the exception of 1 dog. In this dog, a simi-
lar peak velocity at the level of FM was measured.
Intraobserver variability for the manual placement and adjustment
of the ROI on the 2D phase images was ≤0.68 cm/s for the SAS of
FM and cervical spine and ≤0.13 cm/s at the level of the mesence-
phalic aqueduct. The 4D PC-MRI images showed marked velocity
noise, to the point that CSF spaces were not detectable anymore.
Hence, CSF flow velocity measurements and visualization of flow
were not possible with the 4D PC-MRI sequence in any of the dogs.
4 | DISCUSSION
The present study provides normative data of CSF flow in a group of
middle-aged neurological healthy dogs as baseline for comparison in
future studies. Ventricular and subarachnoid CSF space abnormalities
are common findings in dogs; however, their relationship to alter-
ations of CSF flow is not well understood and poorly investigated.
PC-MRI is routinely used as a method to quantify CSF flow in
humans but needs adaptation for use in veterinary patients, because
of the small CSF spaces,30,31 slow CSF flow velocities, and higher
heart rate compared to humans.29 The small CSF spaces require
smaller voxel sizes that lead to a reduced SNR. Compensation can be
achieved by an increased FOV or increased NSA, which produces pro-
longation of scan time.19,20,34 The peak velocities in dogs were
approximately 20% lower compared to humans.9,15,16,21,29,35 Lower
flow velocities lead to higher velocity noise and require lowering of
the velocity encoding. Reducing the velocity encoding results in an
increased TR, which is accompanied by increased scan time.19,20,22,34
Finally, PC-MRI is cardiac gated, meaning that a cardiac gradient is
applied in synchronization with the R-R interval, the time elapsed
between 2 successive R waves of the QRS signal on the electrocardio-
gram. A higher heart rate leads consequently to a smaller R-R interval
and therefore a shorter time to collect flow data and might result in
longer acquisition time or even abortion of the sequence.19,20 The
phantom was built to mimic the conditions in veterinary patients, and
sequence parameters were adapted until a satisfactory SNR within a
clinically reasonable acquisition time of 3 to 4 minutes was achieved.
The sequence parameters developed on the phantom were then
applied in dogs, demonstrating that the phantom allowed us to opti-
mize the 2D PC-MRI sequence without having a dog in the scanner
under general anesthesia. This is in line with 3R requirements and
demonstrates that phantom studies in MRI could help to refine proto-
cols before use on living animals and consequently reduce anesthesia
time and risk. Furthermore, the use of the phantom allowed us to
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demonstrate that 2D PC-MRI provides data corresponding to the cal-
culated flow velocities in tubes. In contrast to 2D PC-MRI where the
velocity can only be decoded in 1 spatial direction, 4D PC-MRI uses
3 bipolar gradients delivering time-resolved CSF flow data in 3 dimen-
sions. This allows the user to determine the exact location of mea-
surement and flow direction in a postprocessing step.21,22,36 Despite
using different acceleration techniques such as kt-BLAST and
SENSE,22,32 an adaptation of velocity encoding <10 cm/s led to scan
times of >20 minutes, which were considered as unacceptable for
clinical use. Therefore, velocity encoding was kept at 10 cm/s, which
resulted in increased velocity noise to such an extent that no mea-
surements could be obtained. Current developments and advances of
acceleration techniques might allow overcoming the challenges of
small CSF spaces and low velocity within reasonable scan times in the
future.
Therefore, the results presented here are limited to 2D PC-MRI
with CSF flow velocities measured at 3 different locations. These
locations play an important role in the pathomechanism of common
disease processes such as stenosis, hydrocephalus and syringomye-
lia.9-11,13,15-18 In addition, measurements at different locations within
1 individual are important, as differences in peak velocity indicate ste-
nosis.29 The measurement at the cranial cervical spine might provide
additional information about intracranial compliance.15
At each of the 3 locations, the peak velocities measured in the
study population of middle aged healthy Beagle dogs were lower than
those measured in humans. This is especially true for the level of the
mesencephalic aqueduct, where values ranging from 3 to 7 cm/s were
obtained in healthy human participants.9,14,37,38 The reason for the
slower flow might be species-related differences such as skull shape,
the orientation of the brain to the spinal cord, or might be due to the
smaller size of dogs compared to humans. Age of the individual could
also play a role since a study comparing CSF flow velocity in human
infants found a higher CSF flow velocity than that in adults.33 To
reduce individual differences in CSF flow velocities, we only included
dogs of the same breed and similar age and therefore similar confor-
mation (size, bodyweight, and skull shape). These inclusion criteria
resulted in a small sample size of 6 individual dogs, and the peak
velocities measured at each of the 3 locations showed only small dif-
ferences between dogs resulting in a small standard variation. Our
results obtained from this small but consistent study sample will
enable future comparison with measurements from larger samples
with individuals of different ages, body weight, or skull shape. This will
allow investigation of factors associated with CSF flow velocities in
dogs. Apart from differences between individual animals, other factors
influence the PC-MRI measurements of CSF flow. First, variation
might arise from the site of measurements, particularly at the level of
the mesencephalic aqueduct, where normal velocities in humans
encompass a broad range from 3 to 7 cm/s. This is probably caused
by setting the phase encoding gradient at either the rostral part,
the ampulla, or the caudal aspect.5,10,17,38-40 The obtained range of
0.51 to 2.08 cm/s in the present study group for the peak velocity
at the level of the aqueduct therefore seems acceptable and was
obtained by defining landmarks during acquisition. Second, varia-
tion might arise from manually placing the ROI in the post-
processing step. Therefore, the use of semiautomatic software for
ROI placement has been suggested.41 The software was not avail-
able for us, and ROI placement was performed 3 times with low
intraobserver variability of 0.68 for all SAS spaces and below 0.13
within the mesencephalic aqueduct. In the present study, manual
ROI placement was a low source of error, but variability between
different observers might be higher. Well-defined landmarks for
both, measurements and ROI placement, seem to be of high impor-
tance to be able to compare velocities. In a previous study, CSF
peak velocities of 59 CKCS dogs were compared to 5 controls,
4 Beagle dogs, and 1 mixed-breed dog. The flow velocities mea-
sured at the FM and mean peak velocity in the ventral and dorsal
SAS of the FM in the control group was 0.75 ± 0.24 cm/s and 0.59
± 0.13 cm/s, respectively.29 The obtained peak velocities of the
control group were lower compared to our study group and veloci-
ties obtained in CKCS were even lower.29 Reasons for the higher
velocities found in the present study might be due to patient-
related factors such as the individual size of CSF space, jugular
venous flow, and compliance of the intracranial space 3-5,15 as well
as the heart rate and respiration rate of the patient,8,33,39,40 all fac-
tors known to influence the CSF flow velocity. A difference in the
examination protocol might have influenced the measurements, all
dogs in the previous study were positioned with the head in a
flexed position. In our study, to facilitate comparison with future
measurements, the dogs were examined with the head in an
extended position, according to our institutional protocol for brain
MRI. However, the extended head position in sternal recumbency
resulted in a narrowing of the dorsal SAS, so that in 2 dogs no CSF
flow data from the phase images could be extracted. It seemed that
the dorsal SAS at the level of the atlantoaxial junction is especially
narrow due to kinking and the dens axis, which displaced the spinal
cord slightly dorsally.30,31 For this reason, we performed an addi-
tional measurement at the level close to the intervertebral disc
space of C2/C3 in 1 of the 6 dogs. This measurement resulted in a
good signal of CSF flow in phase images. Therefore, cervical CSF
flow measurements close to the intervertebral junction C2/C3 with
well visible SAS spaces might be more reliable and clinically useful
rather than the atlantoaxial junction. Furthermore, examinations in
TABLE 1 Mean peak velocity in cm/s and SD of all 6 dogs for the different locations
Foramen magnum Cervical spine
Mesencephalic aqueduct Ventral right Ventral left Dorsal Ventral right Ventral left Dorsal
Mean peak
velocity in cm/s
0.92 ± 0.5 1.78 ± 0.7 1.9 ± 0.8 1.17 ± 0.4 2.15 ± 0.8 1.91 ± 0.5 1.27 ± 0.4
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dorsal recumbency might facilitate visualization of the dorsal SAS,
but the influence of this nonphysiologic position in dogs on visuali-
zation and resulting flow parameters is yet unknown.
The anesthesia protocol for this study was chosen because of the
relatively low effects on the cardiovascular system. Of note, inhala-
tional anesthetic agents could have a cerebral vasodilating effect and
might increase cerebral blood volume and hence intracranial pressure,
if the systemic blood pressure is below 60 mm Hg.42 To avoid differ-
ences related to physiological parameters, a standardized anesthesia
protocol, monitoring and consistent conditions are important. Mea-
surements performed under constant heart rate seem important to be
able to detect differences in flow velocities at different locations in
1 animal. The obtained flow velocities in our dogs suggest that if at
1 location the flow velocity is lower (see Table 1, dog 5), the velocities
at the other locations are lower too, and vice versa (see Table 1, dogs
1 and 2). Differences between high and low velocities indicate a ste-
notic flow pattern and might allow identification of locations of steno-
sis in dogs. Similar to the previous study in dogs, 29 peak velocities
were lower in all dorsal SAS compared to the ventral SAS. A reduced
peak velocity within the dorsal SAS at the level of the FM was
observed in CKCS compared to the control group, irrespective of
signs of syringomyelia or Chiari-like malformation.29 It is unclear if
such differences in flow velocity are due to morphological abnormali-
ties present in CKCS, and further comparison with other dog
populations will shed further light on this question.
The diagnostic value of PC-MRI in dogs needs to be investigated
in future studies. Currently, it is unclear if the method will help to
identify sites of stenosis or explain other alterations of CSF spaces.
Further future applications of CSF flow measurements are the assess-
ment of the intracranial compliance.15,43-45 As a first step, it was
important to develop an examination protocol suitable for the clinical
setting and to have velocity data available from neurologically healthy
dogs as a baseline for further comparisons. Possibly, single sequence
parameters might need to be adapted for different scanner types, but
especially the information about velocity encoding and the resulting
flow velocities are of value for future applications. In conclusion, we
provide a 2D PC-MRI examination protocol with measurements at
3 different locations that seems suitable for the clinical setting. The
acquired CSF flow from 2D PC-MRI of healthy dogs provides norma-
tive values for future applications in research and clinical tests.
ACKNOWLEDGMENTS
Funding provided by Albert Heim foundation of the Swiss Cynological
Society, Switzerland. The authors thank the dedicated co-founder of
Gyrotool LLC Gérard Crelier for his support with the 4D PC-MRI
sequence and Noam Alperin for his generous support.
CONFLICT OF INTEREST DECLARATION
Authors declare no conflict of interest.
OFF-LABEL ANTIMICROBIAL DECLARATION
Authors declare no off-label use of antimicrobials.
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE
(IACUC) OR OTHER APPROVAL DECLARATION
Approved by the Cantonal Veterinary Office of Zurich according to
the Swiss national animal protection law with the animal permission
number ZH2016/17.
HUMAN ETHICS APPROVAL DECLARATION





1. Di Terlizzi R, Platt S. The function, composition and analysis of cere-
brospinal fluid in companion animals: part I—function and composi-
tion. Vet J. 2006;172:422-431.
2. Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic
system: a beginner's guide. Neurochem Res. 2015;40:2583-2599.
3. Baledent O, Henry-Feugeas MC, Idy-Peretti I. Cerebrospinal fluid
dynamics and relation with blood flow: a magnetic resonance study
with semiautomated cerebrospinal fluid segmentation. Invest Radiol.
2001;36:368-377.
4. Bhadelia RA, Bogdan AR, Wolpert SM. Analysis of cerebrospinal fluid
flow waveforms with gated phase-contrast MR velocity measure-
ments. Am J Neuroradiol. 1995;16:389-400.
5. Lee JH, Lee HK, Kim JK, Kim HJ, Park JK, Choi CG. CSF flow quantifi-
cation of the cerebral aqueduct in normal volunteers using phase con-
trast cine MR imaging. Korean J Radiol. 2004;5:81-86.
6. Muehlmann M, Steffinger D, Peraud A, et al. Non-invasive estimation
of intracranial pressure: MR-based evaluation in children with hydro-
cephalus. Radiologe. 2012;52:827-832.
7. Tain RW, Alperin N. Noninvasive intracranial compliance from MRI-
based measurements of transcranial blood and CSF flows: indirect
versus direct approach. IEEE Trans Biomed Eng. 2009;56:544-551.
8. Yamada S, Miyazaki M, Yamashita Y, et al. Influence of respiration on
cerebrospinal fluid movement using magnetic resonance spin labeling.
Fluids Barriers CNS. 2013;10:36.
9. Abbey P, Singh P, Khandelwal N, Mukherjee KK. Shunt surgery
effects on cerebrospinal fluid flow across the aqueduct of Sylvius in
patients with communicating hydrocephalus. J Clin Neurosci. 2009;16:
514-518.
10. Battal B, Kocaoglu M, Bulakbasi N, Husmen G, Tuba Sanal H,
Tayfun C. Cerebrospinal fluid flow imaging by using phase-contrast
MR technique. Brit J Radiol. 2011;84:758-765.
11. Mauer UM, Gottschalk A, Mueller C, Weselek L, Kunz U, Schulz C.
Standard and cardiac-gated phase-contrast magnetic resonance imag-
ing in the clinical course of patients with Chiari malformation type I.
Neurosurg Focus. 2011;31:E5.
12. Quencer RM. Intracranial CSF flow in pediatric hydrocephalus: evalu-
ation with cine-MR imaging. Am J Neuroradiol. 1992;13:601-608.
13. Sharma AK, Gaikwad S, Gupta V, Garg A, Mishra NK. Measurement
of peak CSF flow velocity at cerebral aqueduct, before and after lum-
bar CSF drainage, by use of phase-contrast MRI: utility in the man-
agement of idiopathic normal pressure hydrocephalus. Clin Neurol
Neurosurg. 2008;110:363-368.
14. Tung H, Liao YC, Wu CC, et al. Usefulness of phase-contrast mag-
netic resonance imaging for diagnosis and treatment evaluation in
patients with SIH. Cephalalgia. 2014;34:584-593.
15. Alperin N, Sivaramakrishnan A, Lichtor T. Magnetic resonance
imaging-based measurements of cerebrospinal fluid and blood flow as
CHRISTEN ET AL. 7
indicators of intracranial compliance in patients with Chiari malforma-
tion. J Neurosurg. 2005;103:46-52.
16. Bae YJ, Lee JW, Lee E, Yeom JS, Kim KJ, Kang HS. Cervical compres-
sive myelopathy: flow analysis of cerebrospinal fluid using phase-
contrast magnetic resonance imaging. Europ Spine J. 2017;26:40-48.
17. Luetmer PH, Huston J, Friedman JA, et al. Measurement of cerebro-
spinal fluid flow at the cerebral aqueduct by use of phase-contrast
magnetic resonance imaging: technique validation and utility in diag-
nosing idiopathic normal pressure hydrocephalus. Neurosurgery.
2002;50:534-543.
18. Stadlbauer A, Salomonowitz E, van der Riet W, Buchfelder M,
Ganslandt O. Insight into the patterns of cerebrospinal fluid flow in
the human ventricular system using MR velocity mapping.
Neuroimage. 2010;51:42-52.
19. Kelly EJ, Yamada S. Cerebrospinal fluid flow studies and recent
advancements. Semin Ultrasound CT MR. 2016;37:92-99.
20. Yamada S, Tsuchiya K, Bradley WG, et al. Current and emerging MR
imaging techniques for the diagnosis and management of CSF flow
disorders: a review of phase-contrast and time-spatial labeling inver-
sion pulse. Am J Neuroradiol. 2015;36:623-630.
21. Bunck AC, Kroger JR, Juttner A, et al. Magnetic resonance 4D flow
characteristics of cerebrospinal fluid at the craniocervical junction
and the cervical spinal canal. Europ Radiol. 2011;21:1788-1796.
22. Stankovic Z, Allen BD, Garcia J, et al. 4D flow imaging with MRI.
Cardiovasc Diagn Ther. 2014;4:173-192.
23. Alperin N, Loftus JR, Oliu CJ, et al. Magnetic resonance imaging mea-
sures of posterior cranial fossa morphology and cerebrospinal fluid
physiology in Chiari malformation type I. Neurosurgery. 2014;75:
515-522.
24. Bittermann S, Lang J, Henke D, Howard J, Gorgas D. Magnetic reso-
nance imaging signs of presumed elevated intracranial pressure in
dogs. Vet J. 2014;201:101-108.
25. Cerda-Gonzalez S, Dewey CW. Congenital diseases of the
craniocervical junction in the dog. Vet Clin North Am Small Anim Pract.
2010;40:121-141.
26. Cerda-Gonzalez S, Dewey CW, Scrivani PV, et al. Imaging features of
atlanto-occipital overlapping in dogs. Vet Radiol Ultras. 2009;50:
264-268.
27. Dewey CW, Marino DJ, Loughin CA. Craniocervical junction abnor-
malities in dogs. New Zeal Vet J. 2013;61:202-211.
28. Przyborowska P, Adamiak Z, Jaskolska M, Zhalniarovich Y. Hydro-
cephalus in dogs: a review. Veterinarni Medicina. 2013;58:73-80.
29. Cerda-Gonzalez S, Olby NJ, Broadstone R, et al. Characteristics of
cerebrospinal fluid flow in Cavalier King Charles Spaniels analyzed
using phase velocity cine magnetic resonance imaging. Vet Radiol
Ultras. 2009;50:467-476.
30. Nickel R, Schummer A, Seiferle E. Zentralnervensystem: Gehirn.
Lehrbuch der Anatomie der Haustiere, Band IV, Nervensystem,
Sinnesorgane, Endokrine Drüsen. Vol. IV. 3rd edition. Berlin: Verlag
P. Parey; 1992:28-227.
31. Evans HE, de Lahunta A. Chapter 16 Spinal Cord and Meninges.
Miller's Anatomy of the Dog. 4th St. Louis, USA: Elsevier; 2013:
589-608.
32. Baltes C, Kozerke S, Hansen MS, Pruessmann KP, Tsao J, Boesiger P.
Accelerating cine phase-contrast flow measurements using k-t BLAST
and k-t SENSE. Magn Reson Med. 2005;54:1430-1438.
33. Iskandar BJ, Haughton V. Age-related variations in peak cerebrospinal
fluid velocities in the foramen magnum. J Neurosurg. 2005;103:
508-511.
34. Yamada S, Miyazaki M, Kanazawa H, et al. Visualization of cerebrospi-
nal fluid movement with spin labeling at MR imaging: preliminary
results in normal and pathophysiologic conditions. Radiology. 2008;
249:644-652.
35. Sakas DE, Korfias SI, Wayte SC, et al. Chiari malformation: CSF flow
dynamics in the craniocervical junction and syrinx. Acta Neurochir.
2005;147:1223-1233.
36. Bunck AC, Kroeger JR, Juettner A, et al. Magnetic resonance 4D flow
analysis of cerebrospinal fluid dynamics in Chiari I malformation with
and without syringomyelia. Euro Radiol. 2012;22:1860-1870.
37. Wagshul ME, Chen JJ, Egnor MR, McCormack EJ, Roche PE. Ampli-
tude and phase of cerebrospinal fluid pulsations: experimental studies
and review of the literature. J Neurosurg. 2006;104:810-819.
38. Kapsalaki E, Svolos P, Tsougos I, et al. Quantification of normal CSF
flow through the aqueduct using PC-cine MRI at 3T. Acta Neurochir
Suppl. 2012;113:39-42.
39. Oner Z, Kahraman AS, Kose E, et al. Quantitative evaluation of nor-
mal aqueductal cerebrospinal fluid flow using phase-contrast cine
MRI according to age and sex. Anat Rec. 2017;300:549-555.
40. Unal O, Kartum A, Avcu S, et al. Cine phase-contrast MRI evaluation
of normal aqueductal cerebrospinal fluid flow according to sex and
age. Diagn Intervent Radiol. 2009;15:227-231.
41. Florez N, Marti-Bonmati L, Forner J, et al. Normal values for cerebro-
spinal fluid flow dynamics in the aqueduct of Sylvius through opti-
mized analysis of phase-contrast MR images. Radiologia. 2009;51:
38-44.
42. Vite CH, Cross JR. Correlating magnetic resonance findings with neu-
ropathology and clinical signs in dogs and cats. Vet Radiol Ultras.
2011;52:S23-S31.
43. Otto KA. Physiology, pathophysiology, and anesthetic management
of patients with neurologic disease. In: Grimm KA, Lamont LA,
Tranquilli WS, eds. Veterinary Anesthesia and Analgesia. New York,
United States: Wiley; 2015:564.
44. Raksin PB, Alperin N, Sivaramakrishnan A, et al. Noninvasive intracra-
nial compliance and pressure based on dynamic magnetic resonance
imaging of blood flow and cerebrospinal fluid flow: review of princi-
ples, implementation, and other noninvasive approaches. Neurosurg
Foc. 2003;e4:14.
45. Hofmann E, Warmuth-Metz M, Bendszus M, et al. Phase-contrast
MR imaging of the cervical CSF and spinal cord: volumetric motion
analysis in patients with Chiari I malformation. Am J Neuroradiol.
2000;21:151-158.
How to cite this article: Christen MA, Schweizer-Gorgas D,
Richter H, Joerger FB, Dennler M. Quantification of
cerebrospinal fluid flow in dogs by cardiac-gated phase-
contrast magnetic resonance imaging. J Vet Intern Med. 2020;
1–8. https://doi.org/10.1111/jvim.15932
8 CHRISTEN ET AL.
